Gastroesophageal Cancer Investigator (Pathology-Focused) – Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
About Us:
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe.
Exciting Opportunity at MSK: Gastroesophageal Cancer Investigator (Pathology-Focused)
Role Overview
The Gastrointestinal Oncology Service in the Division of Solid Tumor Oncology is seeking an investigator with formal training in anatomic/surgical pathology and a strong interest in translational research in gastroesophageal cancers.
The selected candidate will be appointed as the Debbie’s Dream Foundation Gastric Cancer Investigator and will provide dedicated pathology expertise to support tissue-based research within the Gastroesophageal Cancer (GEC) Therapeutics Accelerator.
Under the mentorship of Yelena Janjigian, MD, Carroll and Milton Petrie Chair, Chief of GI Oncology and Founding Director of the MSK GEC Therapeutics Accelerator the investigator will receive up to two years of protected research time to focus on biomarker development, tumor microenvironment studies, and integrated translational research.
Key Requirements
MD or MD/PhD with training in anatomic/surgical pathology
Experience in translational or tissue-based cancer research
Preferred: GI pathology experience; familiarity with digital or multiplex pathology methods.
Core Skills:
Provide expert pathologic interpretation for biospecimens from gastric and esophageal cancer trials
Support tissue-based biomarker and translational studies within GECT
Integrate pathology with molecular, genomic, and clinical data
Contribute to grants and peer-reviewed publications
Submit C.V., letter of interest, and three references in your application submission to:
Patrick Evans, Senior Project Manager
Learn more about working as a Post-Doctoral at MSK: What distinguishes this opportunity is you will gain access to high-quality facilities, innovative technologies, and a collaborative environment that promotes ingenuity. Collaborating with leading professionals in genetic epidemiology and computational genomics, you will contribute to groundbreaking research that can revolutionize patient outcomes globally.
Salary Range: $80,000 - $105,000
Helpful links:
Review Our Great Benefits Offerings
Physician compensation is based on multiple variables. This range represents annual salary only and does not include supplemental performance-based pay or any one-time payments that eligible candidates may be offered at the time of hire.
Pay Range: $0.00 - $10,000,000.00FSLA Status: ExemptClosing:
At MSK, we believe in fair, competitive pay that reflects your job, experience, and skills.
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.